These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30776252)

  • 1. Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy.
    Nota NM; Wiepjes CM; de Blok CJM; Gooren LJG; Kreukels BPC; den Heijer M
    Circulation; 2019 Mar; 139(11):1461-1462. PubMed ID: 30776252
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
    Streed CG; Harfouch O; Marvel F; Blumenthal RS; Martin SS; Mukherjee M
    Ann Intern Med; 2017 Aug; 167(4):256-267. PubMed ID: 28738421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone Therapy and Venous Thromboembolism in a Transgender Adolescent.
    Stanley K; Cooper J
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e38-e40. PubMed ID: 28945660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Therapy for Gender Transitions and Health Screenings in Transgender Older Adults.
    Mahan RJ; Bailey TA; Bibb TJ; Fenney M; Williams T
    J Am Geriatr Soc; 2016 Dec; 64(12):2554-2559. PubMed ID: 27996106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis.
    Maraka S; Singh Ospina N; Rodriguez-Gutierrez R; Davidge-Pitts CJ; Nippoldt TB; Prokop LJ; Murad MH
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3914-3923. PubMed ID: 28945852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance.
    Bourgeois AL; Auriche P; Palmaro A; Montastruc JL; Bagheri H
    Ann Endocrinol (Paris); 2016 Feb; 77(1):14-21. PubMed ID: 26830952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population.
    Alzahrani T; Nguyen T; Ryan A; Dwairy A; McCaffrey J; Yunus R; Forgione J; Krepp J; Nagy C; Mazhari R; Reiner J
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005597. PubMed ID: 30950651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Getahun D; Nash R; Flanders WD; Baird TC; Becerra-Culqui TA; Cromwell L; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Safer J; Slovis J; Tangpricha V; Goodman M
    Ann Intern Med; 2018 Aug; 169(4):205-213. PubMed ID: 29987313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in transgender people: recent research and emerging evidence.
    Connelly PJ; Delles C
    Cardiovasc Res; 2021 Dec; 117(14):e174-e176. PubMed ID: 34568899
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
    BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen and anti-androgen therapy for transgender women.
    Tangpricha V; den Heijer M
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):291-300. PubMed ID: 27916515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjectures concerning cross-sex hormone treatment of aging transsexual persons.
    Gooren L; Lips P
    J Sex Med; 2014 Aug; 11(8):2012-9. PubMed ID: 24775178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
    Gooren LJ; Giltay EJ; Bunck MC
    J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
    Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
    Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compromised endothelial function in transgender men taking testosterone.
    Gulanski BI; Flannery CA; Peter PR; Leone CA; Stachenfeld NS
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):138-144. PubMed ID: 31765022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrative genital pain in transgender men using testosterone: a survey study.
    Goetsch MF; Ribbink PJA
    Am J Obstet Gynecol; 2022 Feb; 226(2):264-270. PubMed ID: 34555318
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration.
    Seiger R; Hahn A; Hummer A; Kranz GS; Ganger S; Woletz M; Kraus C; Sladky R; Kautzky A; Kasper S; Windischberger C; Lanzenberger R
    Psychoneuroendocrinology; 2016 Dec; 74():371-379. PubMed ID: 27744092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
    Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
    Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk.
    Martinez C; Rikhi R; Haque T; Fazal A; Kolber M; Hurwitz BE; Schneiderman N; Brown TT
    Curr Probl Cardiol; 2020 May; 45(5):100396. PubMed ID: 30340769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.